首站-论文投稿智能助手
典型文献
Iron metabolism, ferroptosis, and lncRNA in cancer:knowns and unknowns
文献摘要:
Cancer cells undergo substantial metabolic alterations to sustain increased energy supply and uncontrolled proliferation. As an essential trace element, iron is vital for many biological processes. Evidence has revealed that cancer cells deploy various mechanisms to elevate the cellular iron concentration to accelerate proliferation. Ferroptosis, a form of cell death caused by iron-catalyzed excessive peroxidation of polyunsaturated fatty acids (PUFAs), is a promising therapeutic target for therapy-resistant cancers. Previous studies have reported that long noncoding RNA (lncRNA) is a group of critical regulators involved in modulating cell metabolism, proliferation, apoptosis, and ferroptosis. In this review, we summarize the associations among iron metabolism, ferroptosis, and ferroptosis-related lncRNA in tumorigenesis. This information will help deepen understanding of the role of lncRNA in iron metabolism and raise the possibility of targeting lncRNA and ferroptosis in cancer combination therapy.
文献关键词:
作者姓名:
Lei QU;Xinyu HE;Qian TANG;Xiao FAN;Jian LIU;Aifu LIN
作者机构:
MOE Laboratory of Biosystem Homeostasis and Protection,College of Life Sciences,Zhejiang University,Hangzhou 310058,China;Cancer Center,Zhejiang University,Hangzhou 310058,China;Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Hangzhou 310058,China;Zhejiang University-University of Edinburgh Institute(ZJU-UoE Institute),Zhejiang University School of Medicine,Zhejiang University,Haining 314400,China;Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province,Affiliated Hangzhou First People's Hospital,Cancer Center,Zhejiang University School of Medicine,Hangzhou 310006,China;College of Medicine and Veterinary Medicine,the University of Edinburgh,Edinburgh EH164SB,UK;Biomedical and Health Translational Research Center of Zhejiang Province,Haining 314400,China;Breast Center of the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;International School of Medicine,International Institutes of Medicine,the Fourth Affiliated Hospital,Zhejiang University School of Medicine,Yiwu 322000,China;ZJU-QILU Joint Research Institute,Hangzhou 310058,China
引用格式:
[1]Lei QU;Xinyu HE;Qian TANG;Xiao FAN;Jian LIU;Aifu LIN-.Iron metabolism, ferroptosis, and lncRNA in cancer:knowns and unknowns)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(10):844-862
A类:
knowns
B类:
Iron,metabolism,ferroptosis,lncRNA,unknowns,Cancer,cells,undergo,substantial,metabolic,alterations,sustain,increased,energy,supply,uncontrolled,proliferation,essential,trace,element,iron,vital,many,biological,processes,Evidence,has,revealed,that,deploy,various,mechanisms,elevate,cellular,concentration,accelerate,Ferroptosis,death,caused,by,catalyzed,excessive,peroxidation,polyunsaturated,fatty,acids,PUFAs,promising,therapeutic,therapy,resistant,cancers,Previous,studies,have,reported,long,noncoding,group,critical,regulators,involved,modulating,apoptosis,In,this,review,we,summarize,associations,among,related,tumorigenesis,This,information,will,help,deepen,understanding,role,raise,possibility,targeting,combination
AB值:
0.668643
相似文献
AMP-activated protein kinase β1 or β2 deletion enhances colon cancer cell growth and tumorigenesis
Fuli Shi;Zhimin Tang;Shanshan Jiang;Zhijuan Xiong;Wansi Zhang;Yuanjun Li;Hui Lin;Zhijun Luo;Ying Ying-Jiangxi Medical Center for Major Public Health Events,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Immunobiology,College of Life Science and Technology,Jinan University,Guangzhou 510632,China;Jiangxi Province Key Laboratory of Tumor Pathogenesis and Molecular Pathology and Department of Pathophysiology,School of Basic Medical Sciences,Nanchang University,Nanchang 330006 China;Institute of Hematological Research,Shaanxi Provincial People's Hospital,Xi'an 710000,China;Departments of Gastroenterology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China
The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
Renhong Yan;Enjun Xie;Yaning Li;Jin Li;Yuanyuan Zhang;Ximin Chi;Xueping Hu;Lei Xu;Tingjun Hou;Brent R.Stockwell;Junxia Mini;Qiang Zhou;Fudi Wang-Westlake Laboratory of Life Sciences and Biomedicine,Key Laboratory of Structural Biology of Zhejiang Province,Institute of Biology,Westlake Institute for Advanced Study,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Department of Biochemistry,School of Medicine,Southern University of Science and Technology,Shenzhen,Guangdong,China;The First Affiliated Hospital,The Fourth Affiliated Hospital,School of Public Health,Institute of Translational Medicine,Cancer Center,State Key Laboratory of Experimental Hematology,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;The First Affiliated Hospital,The Second Affiliated Hospital,Basic Medical Sciences,School of Public Health,Hengyang Medical School,University of South China,Hengyang,Hunan,China;Beijing Advanced Innovation Center for Structural Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou,Jiangsu,China;Department of Biological Sciences and Department of Chemistry,Columbia University,New York,NY,USA
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
Quantitative proteomics revealed extensive microenvironmental changes after stem cell transplantation in ischemic stroke
Yao Chen;Fahuan Song;Mengjiao Tu;Shuang Wu;Xiao He;Hao Liu;Caiyun Xu;Kai Zhang;Yuankai Zhu;Rui Zhou;Chentao Jin;Ping Wang;Hong Zhang;Mei Tian-Department of Nuclear Medicine and Medical PET Center,The Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310009,China;Institute of Nuclear Medicine and Molecular Imaging,Zhejiang University,Hangzhou 310009,China;Key Laboratory of Medical Molecular Imaging of Zhejiang Province,Hangzhou 310009,China;Department of Radiology,Zhejiang Hospital,Hangzhou 310030,China;Department of PET Center The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310006,China;Key Laboratory for Biomedical Engineering of Ministry of Education,Zhejiang University,Hangzhou 310027,China;College of Biomedical Engineering and Instrument Science,Zhejiang University,Hangzhou 310027,China;Shanxi Medical University,Taiyuan 030001,China
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。